ARCELLX
Startup
ARCELLX
Description
Arcellx develops a novel D-Domain technology, a synthetic binding scaffold designed for advancing cell therapies by enhancing safety, efficacy, and access.
Resources
ARCELLX
Address
United States
Contact
info@arcellx.com
Description
Arcellx develops a novel D-Domain technology, a synthetic binding scaffold designed for advancing cell therapies by enhancing safety, efficacy, and access.
Resources
Matchmaking
Connect with ARCELLX
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways